Has Hassan Farrag, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,078 in general payments to Hassan Farrag, MD across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hassan Farrag, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hassan Farrag, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hassan Farrag, MD

Psychiatry · Northridge, CANPI 1770684896

Payments from drug & device makers

$2,078in general payments, 2019–2025

Across 83 payments — averaging $25.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Neurocrine Biosciences, Inc.$262
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$68
Otsuka America Pharmaceutical, Inc.$49
Teva Pharmaceuticals USA, Inc.$44
E.r. Squibb & Sons, L.L.C.$39
plus $39 from 2 others

What the payments were for

Food & beverage$2,03198%
Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	58	$1,577
Neurocrine Biosciences, Inc.	16	$262
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$68
Otsuka America Pharmaceutical, Inc.	2	$49
Teva Pharmaceuticals USA, Inc.	2	$44
E.r. Squibb & Sons, L.L.C.	1	$39
Johnson & Johnson	1	$26
Alkermes, Inc.	1	$14

How this compares

$2,078 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$285,373

Medicare patients

738

Services billed

4,472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Quetiapine Fumarate	222	$6,476
Aripiprazole	80	$5,990
Lurasidone Hcl	13	$3,062
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	18	$2,486
Divalproex Sodium ErDivalproex Sodium	43	$2,373
Olanzapine	135	$2,349
Clozapine OdtClozapine	32	$2,257
Divalproex Sodium	81	$2,176
Clozapine	45	$2,152
Risperidone	135	$2,073
Haloperidol	30	$1,717
Fluvoxamine Maleate	26	$1,581
Escitalopram Oxalate	81	$1,001
Fluoxetine Hcl	88	$990
Trazodone Hcl	81	$878

Paid to pharmacies, not to this prescriber.

Other psychiatry in Northridge

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →